GRP and neoplasm: In contrast, the bombesin-targeted radioconjugate gradually accumulated in the tumour tissue, displaying enhanced tumour-to-surrounding tissue contrast and significantly higher tumour accumulation levels (3.5 and 5.0% (ID/g after 1 and 6 h, respectively).